SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Kleynhans, Jackie ; Tempia, Stefano ; Wolter, Nicole ; von Gottberg, Anne ; Bhiman, Jinal N. ; Buys, Amelia ; Moyes, Jocelyn ; McMorrow, Meredith L. ; Kahn, Kathleen ; Gómez-Olivé, F. Xavier ; Tollman, Stephen ; Martinson, Neil A. ; Wafawanaka, Floidy ; Lebina, Limakatso ; du Toit, Jacques D. ; Jassat, Waasila ; Neti, Mzimasi ; Brauer, Marieke ; Cohen, Cheryl
• Corporate Authors:
  for the PHIRST-C Group1
• Description:
  By November 2021, after the third wave of severe acute respiratory syndrome coronavirus 2 infections in South Africa, seroprevalence was 60% in a rural community and 70% in an urban community. High seroprevalence before the Omicron variant emerged may have contributed to reduced illness severity observed in the fourth wave.
• Subjects:
  COVID-19 Humans SARS-CoV-2 Seroepidemiologic Studies
• Source:
  Emerg Infect Dis. 2022; 28(5):1055-1058
• Pubmed ID:
  35320701
• Pubmed Central ID:
  PMC9045427
• Document Type:
  Journal Article
• Genre:
  Research Letter
• Place as Subject:
  South Africa
• Volume:
  28
• Issue:
  5
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:b94e71337fb04a62ab60d7436092f09c33a1d46116583e439540eed5cf356151
• Download URL:
  https://stacks.cdc.gov/view/cdc/117308/cdc_117308_DS1.pdf
• File Type:
  [PDF - 636.57 KB ]